This decreases glutathione levels as your reserves are drained, fighting the effects of smoking
The word may is important here because research is still developing
Wegovy, Saxenda and Zepbound are approved for weight loss in the following individuals: Adults with an initial BMI of 30, defined as obesity Adults with an initial BMI of 27, defined as overweight, with at least one weight-related comorbid condition Weight-related comorbid conditions include high blood pressure, cardiovascular disease (such as coronary artery disease, heart attack or heart failure), high cholesterol, obstructive sleep apnea, type 2 diabetes, fatty liver, GERD/acid reflux, osteoarthritis, urinary incontinence, etc
Most patients find symptoms improve within the first month or two
doi: 10.3390/antiox11040745 13 AgarwalASenguptaPDurairajanayagamD